Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Objet Launches New Bio-Compatible 3D Printing Material for Medical and Dental Solutions


News provided by

Objet Geometries Ltd.

21 Sep, 2011, 18:05 GMT

Share this article

Share toX

Share this article

Share toX

REHOVOT, Israel, September 21, 2011 /PRNewswire/ --

- Improved material transparency provides better visibility of soft tissues during medical and dental procedures

Objet Ltd., the innovation leader in 3D printing for rapid prototyping and additive manufacturing, today launched a new Bio-Compatible 3D printing material (MED610™). According to Objet, the material combines bio-compatibility with high dimensional stability and clear transparency. This makes it useful for PMMA simulation and a wide range of medical and dental applications - particularly the production of highly accurate, customized surgical guides.

Dr. Stan Brodie, Specialist in Digital Implant Planning and Surgical Guides at iDent, and a user of Objet 3D printing technology, comments, "The accuracy and fine detail of Objet 3D-printed surgical guides guarantee surgeons a consistently high level of precision that's unmatched by manual processes. The new Bio-Compatible material now introduces further benefits to the process with improved transparency, making it easier to monitor underlying soft tissue during dental procedures."

Avi Cohen, Head of Medical Solutions at Objet adds, "Objet invests significantly in R&D in order to proactively meet the requirements of our customers. The advanced mechanical properties of the new Bio-Compatible material, including its clear transparency bring benefits to the entire medical and dental workflow - from surgical planning through to the procedure itself."

The new Objet Bio-Compatible material is ideal for prolonged skin contact of over 30 days and mucosal-membrane contact of up to 24 hours. It has five medical approvals according to the harmonized standard ISO 10993-1: Cytotoxicity, Genotoxicity, Delayed Type Hypersensitivity, Irritation and USP Plastic Class VI.* MED610 is also manufactured under the ISO 13485:2003 certification, which specifies that each and every batch of the material undergoes bio-compatibility conformity testing, including GC-FID before it is packaged. This ensures the highest bio-compatible standards for medical and dental application requirements.

MED610 is the second material the company has created specifically for dental and medical applications. It joins the company's original Objet VeroDent material, currently used extensively by dental labs worldwide in the digital dental process.

The Bio-Compatible material can be used on all Objet Connex and Eden 3D printers and is available for purchase immediately. Existing customers can use this material following a software upgrade.

*Biological Testing: Parts printed by Objet according to Objet MED610 Use and Maintenance Terms (DOC-08242) were evaluated for biocompatibility in accordance with standard DIN EN ISO 10993-1: 2009, Biological evaluation of medical devices-Part 1: Evaluation and Testing within a risk management process. This addresses cytotoxicity, genotoxicity, delayed hypersensitivity, and USP plastic Class VI which includes the test for irritation, acute systemic toxicity and implantation.

DISCLAIMER: It is the responsibility of the Customer and its respective customers and end-users to determine the biocompatibility of all the component parts and materials used in its finished products for their respective purposes, including in relation to prolonged skin contact (of more than 30 days) and short-term mucosal-membrane contact (up to 24 hours). Results may vary if different conditions apply than those existing at Objet Ltd.'s ("Objet")  laboratories at testing time and those that applied for the purposes of the evaluation of biological testing specified in 2009, Biological evaluation of medical devices-Part 1: Evaluation and Testing within a risk management process. Customer acknowledges the contents of this document and that Objet parts, materials, and supplies are subject to its standard terms and conditions identified at http://www.objet.com/termsandconditions/  which are incorporated herein by reference.

Objet does not guarantee the final release and availability of materials, products and/or features referred to herein. Materials will be released subject to Objet's sole discretion. Not all released materials are currently available for all platforms / systems. Objet will update its website further as releases become available and/or compatible with specific platforms/systems.

About Objet

Objet Ltd., is a leading provider of high quality, cost effective inkjet-based 3D printing systems and materials. A global company, Objet has offices in North America, Europe, Japan, China, Hong Kong, and India.

Objet's 3D printing systems and 3D printing materials are ideal for any company involved in the manufacture or design of physical products using 3D software or other 3D content. Companies using Objet's solutions can be typically found in sectors such as consumer goods & electronics, aerospace & defense, automotive, education, dental, medical and medical devices, architecture, industrial machinery, footwear, sporting goods, toys and service bureaus.

Founded in 1998, the company has thousands of customers worldwide including a substantial share of the relevant Fortune 100 and Fortune 500. Its award-winning technology (12 awards in 5 years) is based upon over 110 patents and patent pending inventions.

Objet's advanced 3D printing systems and range of over 60 materials enable professionals to build prototypes that accurately simulate the true look, feel and function of an end-product, even complex, assembled goods. The Objet Connex™ line of multi-material 3D printers features the world's only technology to simultaneously jet 2 materials. With this, users can print many different materials into a single part and print various mixed parts on the same build tray. Users can also create advanced composite materials, or Digital Materials™ featuring unique mechanical and thermal properties. Objet's range of over 60 3D printing materials simulate properties ranging from rigid to rubber-like, transparent to opaque and standard to ABS-grade engineering plastics, with a large number of in-between shore grades and shades.

Objet's 3D printers are available in a range of form-factors, from cost-effective desktop 3D printers ideal for entry-level professionals all the way to industrial-scale multi-material machines for front-line designers and top manufacturers. Objet's 3D printers feature the industry's highest-resolution 3D printing quality, based on 16-micron (0.0006 in.) super-thin layering, wide material versatility, office friendliness and ease of operation.

For more information, visit us at http://www.objet.com, and for more about 3D printing industry-related news, business issues and trends, read the Objet blog.

© 2011 Objet, Objet24, Objet30, Objet Studio, Quadra, QuadraTempo, FullCure, SHR, Eden, Eden250, Eden260, Eden260V, Eden330, Eden350, Eden350V, Eden500V, Job Manager, CADMatrix, Connex, Connex260, Connex350, Connex500, Alaris, Alaris30, PolyLog, TangoBlack, TangoGray, TangoPlus, TangoBlackPlus, VeroBlue, VeroBlack, VeroClear, VeroDent, VeroGray, VeroWhite, VeroWhitePlus, Durus, Digital Materials, PolyJet, PolyJet Matrix, ABS-like and ObjetGreen are trademarks or registered trademarks of Objet Geometries Ltd. and may be registered in certain jurisdictions. All other trademarks belong to their respective owners.

Objet Media Contacts

  
   USA                                   Europe                
    Robyn Stein                           Claire Russell-Jones        
    Gabbegroup                            UK Bespoke            
    Tel. +1 212 220 4444                  Tel: +44 1737 215200        
    Email. robyn.stein@gabbe.com          E-mail. claire@bespoke.co.uk    
   
   Objet
    Arita Mattsoff
    Objet
    Tel. +972 8 931 4314
    Email. arita@objet.com
   
  
   Asia Pacific                         Japan                
    Jenny Chan                           Masaya Takahama        
    The Hoffman Agency                   The Hoffman Agency, Japan    
    Tel: +81 3 2231 8101                 Tel: +81 3 5159 2145        
    E-mail. jchan@hoffman.com           Email. mtakahama@hoffman.com    
   
   China
    Dong Chen
    The Hoffman Agency, China
    Tel. +86 21 6391 5869
    Email. dchen@hoffman.com
   
   India                                Korea                
    Shivalika Chadha                     Jihyun Lee            
    Avian Media                          The Hoffman Agency Korea    
    Tel. + 91 9717838601                 Tel. +82-10-3408-1609        
    Email. shivalika@avian-media.com     Email. jhlee@hoffman.com        
   
   Mexico
    Patricia Tawill
    IDESA
    Tel. +52 55 5253 9670
    Email. ptawil@idesap.com
   
   
   South Africa
    Alison McDonald
    PR Connections
    Tel. +27 (0) 11 468 1192
    Email. alison@pr.co.za

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.